Read Larry Connors' blog – Short Term Trading Strategies
(Logo: http://www.newscom.com/cgi-bin/prnh/20090326/SF89756LOGO)
"The goal of this cord blood education program is to help physicians, and other labor and delivery specialists, provide expecting parents with scientifically-accurate information in a compelling format so they can make an informed choice about the options for preserving their newborn's cord blood stem cells," said Heather Brown, MS, CGC, vice president scientific & medical affairs at Cord Blood Registry. "This Web-based system offers many advantages in that it is accessible at any time of day, it's easily shared with spouses and other family members, and can provide documentation of the patient's education and informed choice, especially where public policy encourages or requires education."
The Institute of Medicine (IOM) recommended in 2005 that pregnant women should be educated on the value of cord blood stem cells early in pregnancy so an informed decision can be made about cord blood banking. In an effort to improve education to expecting parents, 17 states representing nearly two-thirds of all births in the U.S. have passed laws to implement the IOM guidance on cord blood education.
Umbilical cord blood is a rich and diverse source of newborn stem cells that can be collected without ethical concerns in a ten minute window immediately after birth. This population of stem cells has been used to treat nearly 80 diseases and is a preferred source of stem cells for clinical research in regenerative medicine because these cells have demonstrated embryonic-like capabilities to proliferate and develop into all of the major cell types in the body.
In parallel to the survey data collection, Cord Blood Registry invited physicians, nurses and other healthcare providers to provide input and perspective on the program. To date, nearly 7,000 healthcare providers have reviewed the on-line education program.
"It's great to finally have an up-to-date, easy-to-understand resource to direct my patients to as they are weighing their cord blood options," said Kelly Harkey, MD, MPH, an obstetrician and gynecologist based in California, which was one of the first states to focus on cord blood awareness. "Because educating patients about cord blood is encouraged in my state, it's nice that at the end of the program, patients are able to confirm they've been educated, which ensures my practice is compliant with state legislation."
The content of the program is divided into segments including a description of cord blood stem cells, the collection and storage process, the use of cord blood in current medical treatments, the latest information on new treatments in development, and the expecting patient's cord blood options. The content is accompanied by video segments and stories of how other families' cord blood banking decision impacted their lives. To use the on-line program, go to: http://www.cordblood.com/learn/.
About Cord Blood Registry
Cord Blood Registry(R) (CBR(R)) is the world's largest stem cell bank, focused on the collection, processing and storage of newborn stem cells from umbilical cord blood and ensuring their viability for medical use. CBR is the most recommended family cord blood bank by obstetricians and was the first family bank accredited by AABB (formerly the American Association of Blood Banks). The company has been profitable and cash flow positive from operations on a cumulative basis since 1999. CBR has processed and stored cord blood units for more than 300,000 newborns from around the world and has released more client cord blood units for specific therapeutic use than any other family cord blood bank. CBR is the leader in research and development efforts in collaboration with the world's leading clinical researchers focused on advancing regenerative medical therapies using a child's own cord blood stem cells. The company continues to enhance its industry-leading technical innovations for stem cell collection, processing and storage that optimize quality and cell yield. For more information, visit www.CordBlood.com.
SOURCE Cord Blood Registry
http://www.cordblood.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
